Skip to main content
Clinical Trials/CTRI/2023/03/050838
CTRI/2023/03/050838
Recruiting
Phase 2

Assessment of the effect of rinsing with aqueous solution of commercially available Vavading powder (Embelia ribes) on Streptococcus mutans in patients undergoing fixed orthodontic treatment: A randomized clinical trial.

Dr Anjali Nandanwar0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Anjali Nandanwar
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Anjali Nandanwar

Eligibility Criteria

Inclusion Criteria

  • Study eligibility will be restricted to those of either gender between the age of 14\-30 years and present at least 20 natural teeth.
  • Subjects in good general and oral health will be enrolled.

Exclusion Criteria

  • Exclusion criteria included pregnancy or breast feeding, systemic diseases, ongoing or scheduled medical treatment during the study period.
  • Patients taking medications including antibiotics or anti\-inflammatory agents in the month during the study duration will be excluded.
  • Patients having allergies to oral hygiene formulations, a history of drug or alcohol abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials